Description
MOD - DECREASE - DIASORIN - 36C25722P0175 - 549C60141
Base award description: NTX FOR IMMUNOCHEMISTRY ANALYZER WITH LABORATORY REAGENTS AND SUPPLIES
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-12-17+$56,669= $56,669
- Mod P000012022-10-06+$8,279= $64,948
- Mod P000022022-10-28+$64,948= $129,896
- Mod P000032023-03-28-$39,949= $89,947
- Mod P000042023-05-04+$6,665= $96,612
- Mod P000052023-10-20+$71,613= $168,225
- Mod P000062024-01-16+$23,567= $191,792
- Mod P000072024-01-29-$750= $191,042
- Mod P000082024-04-26+$2,500= $193,542
- Mod P000092024-10-31+$0= $193,542
- Mod P000102024-11-04+$95,180= $288,722
- Mod P000112025-04-17-$4,775= $283,947
- Mod P000122025-12-04+$16,032= $299,979
- Mod P000132026-04-23-$11,195= $288,783
- Mod P000142026-04-27-$14,648= $274,135
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-12-17 | +$56,669 | $56,669 | NTX FOR IMMUNOCHEMISTRY ANALYZER WITH LABORATORY REAGENTS AND SUPPLIES |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-10-06 | +$8,279 | $64,948 | NTX FOR IMMUNOCHEMISTRY ANALYZER WITH LABORATORY REAGENTS AND SUPPLIES |
| Mod P00002· EXERCISE AN OPTION | 2022-10-28 | +$64,948 | $129,896 | OY1 NTX IMMUNOCHEMISTRY ANALYZER AND SUPPLIES |
| Mod P00003· FUNDING ONLY ACTION | 2023-03-28 | −$39,949 | $89,947 | MOD BASE DECREASE - NTX DIASORIN IMMUNOCHEMISTRY ANALYZER AND SUPPLIES |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-05-04 | +$6,665 | $96,612 | NTX DIASORIN IMMUNOCHEMISTRY ANALYZER AND SUPPLIES |
| Mod P00005· EXERCISE AN OPTION | 2023-10-20 | +$71,613 | $168,225 | OY2 DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-16 | +$23,567 | $191,792 | DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-01-29 | −$750 | $191,042 | DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00008· FUNDING ONLY ACTION | 2024-04-26 | +$2,500 | $193,542 | DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-10-31 | +$0 | $193,542 | DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00010· EXERCISE AN OPTION | 2024-11-04 | +$95,180 | $288,722 | DIASORIN IMMUNOCHEMISTRY ANALYZER/SUPPLIES (NTX) |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-17 | −$4,775 | $283,947 | DIASORIN IMMUNOCHEMISTRY ANALYZER SUPPLIES NTX - MOD - DECREASE |
| Mod P00012· EXERCISE AN OPTION | 2025-12-04 | +$16,032 | $299,979 | DIASORIN IMMUNOCHEMISTRY ANALYZER OPT - 36C25722P0175 - TWO-MONTH EXTENSION |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-23 | −$11,195 | $288,783 | MOD - DECREASE - DIASORIN - 36C25722P0175 - 549C50160 |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-04-27 | −$14,648 | $274,135 | MOD - DECREASE - DIASORIN - 36C25722P0175 - 549C60141 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FGK2QR959BV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0641 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $172,138 | FY2026 |
| 36C24426A0041 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36C24426N0964 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $45,218 | FY2026 |
| 36C24426N0963 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $244,586 | FY2026 |
| 36C26026N0382 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q301 · REFERENCE LABORATORY TESTING | $125,000 | FY2026 |
| 36C24426N0738 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $78,181 | FY2026 |
Other recipients under Q301 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0415 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $27,000 | FY2026 |
| 36C25726N0419 | EXACT SCIENCES CORPORATION | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $127,174 | FY2026 |
| 36C25726N0422 | PROPATH SERVICES, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,531,914 | FY2026 |
| 36C25726N0390 | NEOGENOMICS LABORATORIES, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $493,650 | FY2026 |
| 36C25726N0382 | BIODESIX, INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,696 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25722P0175_3600_-NONE-_-NONE- · retrieved 2026-09-26.